Alum Or Burnt Alum Patents (Class 424/698)
-
Publication number: 20140294995Abstract: The present invention relates to a pharmaceutical formulation containing a combination of (a) at least one astringent active substance and (b) at least one mucilaginous drug and the use thereof for the prevention or treatment of inflammatory diseases of the oropharyngeal region and for the treatment of painful irritations of the mucosa in the oropharyngeal region and associated irritable cough.Type: ApplicationFiled: April 1, 2014Publication date: October 2, 2014Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBHInventors: Julia BONI, Bernd PLOHMANN, Sandra SAUERLAND
-
Patent number: 8821904Abstract: A topical composition and its use for the prophylaxis and the treatment of defects connected to inflammatory dermopathies. Particularly, a topical composition including at least an alum, 18-?-glycyrrhetic acid and/or one derivative thereof, and vitamin A and/or one derivative thereof, and the use of such composition for the prophylaxis and the treatment of inflammatory dermopathies, preferably of the seborrhoeic dermatitis and of those affections in which the presence of an excess of sebum occurs.Type: GrantFiled: May 4, 2011Date of Patent: September 2, 2014Assignee: Skinius S.R.L.Inventor: Antonino Di Pietro
-
Publication number: 20140161903Abstract: The invention features topical formulations comprising an osmotically active agent and/or a vasoconstrictor and/or an astringent agent for the treatment and prevention of eyelid swelling, and methods of use thereof.Type: ApplicationFiled: February 12, 2014Publication date: June 12, 2014Applicant: ACIEX THERAPEUTICS, INC.Inventors: Matthew J. Chapin, Mark Barry Abelson, Keith Jeffrey Lane, Akimitsu Makino
-
Patent number: 8741353Abstract: The ointment for healing burns and wounds includes a composition for treating skin burns, wounds, and other infection-prone skin complications. The composition includes honeycomb, sesame seed oil, myrrh, curcumin, mukul, and potassium alum. The ointment includes only natural ingredients that are unadulterated or minimally processed. Topical use of the ointment does not result in harmful side effects.Type: GrantFiled: January 27, 2014Date of Patent: June 3, 2014Inventor: May Ghaith M. Al-Mutawaa
-
Patent number: 8658193Abstract: Technologies are described herein for styptic compounds comprising a hemostatic or styptic agent suspended within a hydrophobic carrier medium. Example carrier mediums may include waxes, lipids, oils, or combinations thereof. The compound may be a semisolid at room temperature and soft enough to be easily dispensed and formed into or onto bleeding tissue of an animal or human. The hydrophobic qualities of the carrier medium can protect the styptic agent from absorbing moisture. The carrier medium can mechanically support positioning treatments adjacent to the bleeding tissue. The carrier medium can further serve to mechanically seal the tissue to aid in hemostasis while also protecting the tissue from debris and contamination. The carrier medium can aid in maintaining moisture within the tissue. Slurry-based manufacturing processes can support a substantially homogeneous dispersal of styptic agent throughout the carrier medium.Type: GrantFiled: June 8, 2012Date of Patent: February 25, 2014Inventor: Robert J. Greenwald
-
Publication number: 20140010896Abstract: In an embodiment of the present invention, a composition for removing a tick and providing relief therefrom comprises a solvent, a carrier fluid suitable for increasing the rate of seepage of the solvent into the host, a solubilizer suitable for increasing the solubility of the composition in water, and a solution that provides soothing and aids in healing the host.Type: ApplicationFiled: July 9, 2013Publication date: January 9, 2014Inventor: Cynthia M. Chapman
-
Patent number: 8460642Abstract: The present invention provides a method of promoting bone growth in a subject in need thereof, by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides methods for the treatment of renal disease and cancer.Type: GrantFiled: April 25, 2012Date of Patent: June 11, 2013Assignee: OssiFi, Inc.Inventors: Debra Ellies, William Rosenberg
-
Publication number: 20130101686Abstract: A topical composition and its use for the prophylaxis and the treatment of defects connected to inflammatory dermopathies. Particularly, a topical composition including at least an alum, 18-?-glycyrrhetic acid and/or one derivative thereof, and vitamin A and/or one derivative thereof, and the use of such composition for the prophylaxis and the treatment of inflammatory dermopathies, preferably of the seborrhoeic dermatitis and of those affections in which the presence of an excess of sebum occurs.Type: ApplicationFiled: May 4, 2011Publication date: April 25, 2013Applicant: SKINIUS S.R.L.Inventor: Antonio DiPietro
-
Publication number: 20120253298Abstract: A tissue thickness compensator may generally comprise a first layer comprising a first medicament, a second layer comprising a second medicament, and a third layer comprising a third medicament. The tissue thickness compensator may comprise a first layer comprising a first medicament, a second layer comprising a second medicament, and a reservoir comprising a third medicament disposed within the reservoir. The medicaments may be independently selected from a haemostatic agent, an anti-inflammatory agent, an antibiotic agent, anti-microbial agent, an anti-adhesion agent, an anti-coagulant agent, a pharmaceutically active agent, a matrix metalloproteinase inhibitor, and combinations thereof. Articles of manufacture comprising the tissue thickness compensator and methods of making and using the tissue thickness compensator are also described.Type: ApplicationFiled: March 28, 2012Publication date: October 4, 2012Applicant: Ethicon Endo-Surgery, Inc.Inventors: Cortney E. Henderson, Taylor W. Aronhalt, Chunlin Yang, Charles J. Scheib, Venkataramanan Mandakolathur Vasudevan, Mark D. Timmer, Richard W. Timm, Tamara Widenhouse, Steven G. Hall
-
Patent number: 8158159Abstract: A pharmaceutical formulation for treating tinea of feet and hands is disclosed, which is composed of Fructus Gleditsia, Alumen and Borneol. Also disclosed is a cream preparative method of the pharmaceutical formulation, which comprises Fructus Gleditsia is decocted with water, and the decocted liquid is dried under decompression into powder, which is formulated to a cream together with the powders of Alumen and Borneol as well as the respective excipients.Type: GrantFiled: February 12, 2007Date of Patent: April 17, 2012Assignee: Shen Zhen Bei Ke Lian Pharmaceutical Sci-Tech Co., Ltd.Inventor: Jinghua Chen
-
Patent number: 8003644Abstract: Biocidal compositions that contain biocidal components, such as an oxidant, and mixed with said components a combination of inorganic compounds capable of reducing the oxidative capacity of the biocidal components by forming a low-melting glass when heated. The biocidal composition may be heated by being ignited or subjected to a heating source, such as a fire.Type: GrantFiled: April 8, 2004Date of Patent: August 23, 2011Assignee: Bromine Compounds Ltd.Inventor: Theodor Morel Fishler
-
Patent number: 7850973Abstract: The invention provides compositions and methods for the treatment of diseases associated with amyloid deposits of A? in the brain of a patient, such as Alzheimer's disease. Such methods entail administering an immunogenic fragment of A?, lacking a T-cell epitope, capable of inducing a beneficial immune response in the form of antibodies to A?. In another aspect, the immunogenic fragment of A? is capable of elevating plasma A? levels. The immunogenic fragments comprise linear or multivalent peptides of A?. Pharmaceutical compositions comprise the immunogenic fragment chemically linked to a carrier molecule which may be administered with an adjuvant.Type: GrantFiled: May 1, 2006Date of Patent: December 14, 2010Assignee: Merck Sharp & Dohme Corp.Inventors: Victor M. Garsky, Joseph G. Joyce, Paul M. Keller, Gene Kinney, Xiaoping Liang, John W. Shiver
-
Patent number: 7824686Abstract: The present invention is concerned with vaccines and their preparation. An effective long-term immune response, especially in mammals, can be produced using a vaccine comprising an antigen encapsulated in liposomes, a suitable adjuvant and a carrier comprising a continuous phase of a hydrophobic substance. The vaccine is particularly effective in eliciting the production of antibodies that recognize epitopes of native proteins.Type: GrantFiled: November 20, 2008Date of Patent: November 2, 2010Assignee: Immunovaccine Technologies, Inc.Inventors: Robert George Brown, Bill Pohajdak, Warwick Charles Kimmins
-
Patent number: 7811554Abstract: The horse liniment is a veterinary composition for topical application for the relief of muscle and joint pain in horses. The composition contains, by weight, about 49% alcohol, 20% olive oil, 10% arnica, 14% creosote, 1% iodine, 2% turpentine, 2% camphor, and 2% alum. The ingredients may be mixed at room temperature, the powdered ingredients being soluble in the alcohol-olive oil base. The composition is applied topically to the affected muscles or joints in conventional manner as needed. The composition has been found to be effective, often with a single application, with increased range of motion, an absence or reduction of limping, increased energy, and other signs of a healthy, active horse.Type: GrantFiled: January 18, 2008Date of Patent: October 12, 2010Inventor: Flavio Lozano
-
Publication number: 20100068306Abstract: An herbal composition capable of helping to speed the body's healing reaction to infection, and methods of treating wounds and infections using such a composition are provided.Type: ApplicationFiled: September 14, 2009Publication date: March 18, 2010Inventor: Chin-Pao Chou
-
Patent number: 7597911Abstract: A selection of herbal materials with curative effects combined in a liquid form and processed into a suitable topical delivery system for application to skin ulcerations, surgical incisions wounds and cuts to accomplish accelerated wound healing. The present invention can also heal and provide 1st and 2nd degree burn, radiation burn and sunburn relief and be used for application to human skin affected with psoriasis, eczema, dermatitis, acne, rosacea, extreme dryness, allergic reactions and inflammatory rashes. The process to manufacture and the herbal extract vehicle of delivery are both critical to the effectiveness of the present invention since the invention is comprised of two separate herbal composition extracts which do not form a homogenous mixture when combined.Type: GrantFiled: August 16, 2002Date of Patent: October 6, 2009Assignee: CuraPharm, Inc.Inventor: Thomas M. Hnat
-
Patent number: 7560099Abstract: A fragrant, topical antiseptic, astringent mixture which eliminates the bumping caused by the use of a razor and/or a depilatory is provided. The aftershave composition includes aluminum potassium sulfate dodecahydrate and an aromatic oil in a 70% by volume solution of isopropyl alcohol.Type: GrantFiled: June 25, 2007Date of Patent: July 14, 2009Inventor: Donald D. Ramsey
-
Patent number: 7498037Abstract: The invention concerns novel Plasmodium falciparum antigens and their vaccine and diagnostic applications. More particularly, the invention concerns immunogenic polynucleotide and polypeptide molecules, compositions comprising them, and methods for diagnosis and vaccination of malaria.Type: GrantFiled: November 14, 2003Date of Patent: March 3, 2009Assignee: Institut PasteurInventors: Pierre Druilhe, Anne-Charlotte Grüner
-
Patent number: 7479282Abstract: This invention provides an isolated polypeptide comprising an amino acid sequence of a N-terminal choline binding protein A truncate in which the amino acid sequence is set forth in any of SEQ ID NOS: 1, 3-7, or 9-11, including fragments, mutants, variants, analogs, or derivatives, thereof. Also, this invention provides a isolated polypeptide comprising an amino acid sequence of a N-terminal choline binding protein A truncate, wherein the amino acid is set forth in SEQ ID NO: 24, wherein the polypeptide retains its native tertiary structure and methods of preparation. This invention provides an isolated polypeptide comprising an amino acid sequence of a N-terminal choline binding protein A truncate, wherein the polypeptide has lectin activity and does not bind to choline. This invention provides an isolated immunogenic polypeptide comprising an amino acid sequence of a N-terminal choline binding protein A truncate.Type: GrantFiled: January 5, 2004Date of Patent: January 20, 2009Assignees: St. Jude Children's Research Hospital, MedimmuneInventors: Elaine I. Tuomanen, Theresa M. Wizemann, H. Robert Masure, Leslie S. Johnson, Scott Koenig
-
Patent number: 7431936Abstract: The present invention provides the RSP-1 and RSP-2 proteins which are involved in the cytoadhesion of P. falciparum during ring-stage infection of erythrocytes, antibodies which bind to the proteins, methods of screening for a P. falciparum infection, methods of determining the infective stage of P. falciparum and vaccines for protecting individuals from Plasmodium sp. infections.Type: GrantFiled: November 29, 2002Date of Patent: October 7, 2008Assignees: Institut Pasteur, Centre National de la Recherche ScientifiqueInventors: Juerg Gysin, Bruno Pouvelle, Artur Scherf, Pierre Buffet
-
Patent number: 7404960Abstract: A vaccine composition comprising two valences is provided: (i) a first valence which is adjuvant-enhanced with aluminum hydroxide and (ii) a second valence which contains a polysaccharide of bacterial capsule comprising one or more o-acetyl groups and which is not adsorbed with aluminum oxide due to the presence of a protecting compound which may be a phosphate, a citrate or a carbonate and which prevents the adsorption. The first valence can be any vaccine valence. In one particular embodiment, the vaccine composition contains (i) Hepatitis A valence, adsorbed on aluminum hydroxide and (ii) the typhoid fever valence formed by the polysaccharide Vi of the Salmonella typhi capsule.Type: GrantFiled: July 31, 2002Date of Patent: July 29, 2008Assignee: Aventis Pasteur SAInventor: Alain Françon
-
Patent number: 7252843Abstract: A composition and method for cleaning, sanitizing and maintaining contained bodies of water such as swimming pools, wading pools, fountains, ornamental ponds, etc. The composition includes pre-determined percentages of copper sulfate, zinc sulfate, and aluminum sulfate by weight. The composition and method reduce amounts of chlorine and an amount of labor associated with the cleaning, sanitization and maintenance of contained bodies of water.Type: GrantFiled: December 13, 2004Date of Patent: August 7, 2007Inventors: David J. Moore, William C. Betts
-
Patent number: 7235266Abstract: Disclosed are a facial pack composition and a bathing composition based on loess, and methods for preparing the same. The bathing composition makes a user feel refreshed, prevents arteriosclerosis and fat accumulation in human bodies, is useful for the treatment of maturating diseases such as dermatophytosis and dermatitis and stimulates metabolism and blood circulation system of the human body. Additionally, the facial pack includes loess having a fine particle size sufficient to avoid skin irritation and thus does not adversely affect the skin even if the user uses the pack everyday. The loess is pretreated by a unique aging method and selected additives, so that the far infrared ray-emitting effect of the loess can be maximized. Therefore, it provides skin health-aid and cosmetic effects.Type: GrantFiled: January 9, 2006Date of Patent: June 26, 2007Inventor: Jang Yong Park
-
Patent number: 7029705Abstract: A method is disclosed of practicing nasal hygiene comprising the steps of applying to a person's nostril a non-irritating hygienic composition consisting essentially of a product of compounding under homogenizing conditions water, 0.01% to 5% by weight, as chlorine dioxide, of a source of chlorine dioxide; 0.01% to 3% by weight of at least one olfactory stimulant, 0 to 5% by weight of at least one fixative compound less volatile than the olfactory stimulant 0.1 to 2.5% by weight of at least one inorganic salt selected from the group consisting of alkali metal chloride, alkali metal bicarbonate, and alkali metal chlorate; and 0.0002 to 0.006% (as aluminum) by weight of at least one water soluble aluminum compound, provided that the total concentration of inorganic salt is in the range from 0.6% by weight to 2.5% by weight, holding the composition within the nostril for a hygienic holding period, and discharging the composition from the treated nostril.Type: GrantFiled: July 30, 2003Date of Patent: April 18, 2006Inventor: Allan H. Fuhr
-
Patent number: 7011824Abstract: A method of treating animal manure solids comprises contacting the solids with a treatment composition comprising AlCl3.nH2O or Al(NO3)3.mH2O, or the residue of AlCl3.nH2O or Al(NO3)3.mH2O, to form a treated waste product, wherein n is from 0 to 10, and m is from 0 to 12. The treatment amount can be effective to reduce phosphorus solubility in the manure; reduce phosphorus runoff and/or phosphorus leaching from fields fertilized with manure; inhibit ammonia volatilization from the manure; flocculate solids in the manure; reduce pathogens in the manure; increase the nitrogen content in the manure; and/or reduce acid rain and PM-10s associated with the manure.Type: GrantFiled: December 4, 2000Date of Patent: March 14, 2006Assignees: The United States of America as represented by the Secretary of Agriculture, The Board of Trustees of the University of ArkansasInventor: Philip A. Moore, Jr.
-
Patent number: 6958159Abstract: The present invention relates to an improved pharmaceutical composition useful for the topical treatment of burns, cuts, wounds, abrasions and the like, and to methods of treatment of injured body surfaces such as skin.Type: GrantFiled: March 26, 2001Date of Patent: October 25, 2005Assignee: Chiltern Pharmaceuticals, Pty Ltd.Inventor: Robert Alan Smith
-
Patent number: 6951651Abstract: We have screened the HCMV-specific T cell clone, 33F4, with a nonamer PS-SCL based on SEQ ID NO: 1, and described a series of analog peptides that are recognized with greater affinity than the native peptide sequence.Type: GrantFiled: August 20, 2003Date of Patent: October 4, 2005Assignee: City of HopeInventor: Don J. Diamond
-
Patent number: 6929800Abstract: A nasal passage cleaning composition according to the invention comprises water and salt as a base, and contains a mucolytic agent such as alum and/or zinc sulphate to shrink the mucosa and allow sinus passage drainage, decreasing pressure in the infected sinus an alleviates sinus headache and face ache. A preferred mucolytic agent is n-acetyl-L-cystine, which is used to dissolve or soften mucus in the nasal passages, though methyl salicylate may also be used to disintegrate crusted mucus, acting also as a topical anti-inflammatory agent and as a pain relieving agent to reduce pain and discomfort.Type: GrantFiled: August 6, 2001Date of Patent: August 16, 2005Inventor: Abdul Rasoul Salman
-
Patent number: 6793923Abstract: The present invention is concerned with vaccines and their preparation. An effective long-term immune response, especially in mammals, can be produced using a vaccine comprising an antigen encapsulated in liposomes, a suitable adjuvant and a carrier comprising a continuous phase of a hydrophobic substance. The vaccine is particularly effective in eliciting the production of antibodies that recognize epitopes of native proteins.Type: GrantFiled: November 6, 2001Date of Patent: September 21, 2004Assignee: Immunovaccine Technologies, Inc.Inventors: Robert George Brown, William Pohajdak, Warwick Charles Kimmins
-
Publication number: 20040175445Abstract: A selection of herbal materials with curative effects combined in a liquid form and processed into a suitable topical delivery system for application to skin ulcerations, surgical incisions wounds and cuts to accomplish accelerated wound healing. The present invention can also heal and provide 1st and 2nd degree burn, radiation burn and sunburn relief and be used for application to human skin affected with psoriasis, eczema, dermatitis, acne, rosacea, extreme dryness, allergic reactions and inflammatory rashes. The process to manufacture and the herbal extract vehicle of delivery are both critical to the effectiveness of the present invention since the invention is comprised of two separate herbal composition extracts which do not form a homogenous mixture when combined.Type: ApplicationFiled: February 13, 2004Publication date: September 9, 2004Inventor: Thomas M. Hnat
-
Patent number: 6696065Abstract: A multi-component vaccine composition is described comprising acellular pertussis vaccine components, diphtheria toxoid, tetanus toxoid and inactivated poliovirus. The composition also may contain a conjugate of a capsular polysaccharide on Haemophilus influenzae type b and tetanus toxoid or diphtheria toxoid, which may be reconstituted from a lyophilized state by the other component. The administration of the multiple component vaccine resulted in no diminution of the immunogenicity of any component as a result of interference by other components of the vaccine.Type: GrantFiled: July 2, 1996Date of Patent: February 24, 2004Assignee: Aventis Pastuer LimitedInventors: Raafat E. F. Fahim, Larry U. L. Tan, Luis Barreto, John Thipphawong, Gail E. D. Jackson
-
Patent number: 6692775Abstract: A gel formulation is combined with a bactericidal concentrate which is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a specific conductance of less than 0.10 mho with about 1.2 to 3 parts by volume of Willard Water as prepared in accordance with U.S. Pat. No. 3,893,943. The bactericidal liquid concentrate in the amount of 3.5 to 12 ml in one liter of gel formulation is applied directly to a skin surface area having a burn or other dermal lesion to protect the area from bacterial contamination.Type: GrantFiled: June 24, 2002Date of Patent: February 17, 2004Assignee: Aqua Med, Inc.Inventor: John D. Young
-
Patent number: 6689392Abstract: A composition for controlling growth of pathological organisms on a plant, said composition comprises an effective amount of one or more of metal ion(s); one or more of chelating agent(s); and phosphorous acid, and/or salt or hydrate thereof, said composition is in an agriculturally compatible carrier or vehicle.Type: GrantFiled: January 29, 2002Date of Patent: February 10, 2004Assignee: Agricare Ltd.Inventor: Ran Lifshitz
-
Patent number: 6685969Abstract: Ectoparasites, such as fleas, ticks, mites and lice, are removed from a human or animal host after applying a composition that causes the temperature of the treated area to become higher or lower than normal. In one embodiment, treatment is effected by applying a composition that releases heat when contacted with water. The elevated or decreased temperature immobilizes the parasites and facilitates their mechanical removal, such as by combing.Type: GrantFiled: June 11, 2001Date of Patent: February 3, 2004Assignee: Schering-Plough HealthCare Products, Inc.Inventors: Kurt G. Van Scoik, Marcia S. Schlesinger
-
Patent number: 6652840Abstract: A composition is disclosed which has been shown to stop or control bleeding and seal open small blood vessels while accelerating the healing process of abraded oral “gum” and other “skin” (epithelial) tissues. The composition is preferably in the form of a paste which promotes ease of application and use of the composition. A variety of instruments can be used in application and cleanup of the composition showing versatile unparalleled friendly usage. The composition preferably comprises aluminum chloride, ferric sulfate (subsulfate), regenerated oxidized cellulose, aluminum ammonium sulfate, absorbable gelatin and a solvent. The composition has many dental and medical procedure applications.Type: GrantFiled: February 8, 2002Date of Patent: November 25, 2003Inventor: Terence Prevendar
-
Patent number: 6641825Abstract: A gentle skin cleansing gel is provided containing as an ingredient, water soluble salts having a negative enthalpy in solution, which when mixed with water release heat which improves the cleansing effect and the release of perfumes creating a pleasant effect on the skin.Type: GrantFiled: August 30, 2002Date of Patent: November 4, 2003Assignee: Henkel Kommanditgesellschaft auf AktienInventors: Wolfhard Scholz, Katrin Meyer zu Schlochtern-Maric, Armin Wadle
-
Patent number: 6576594Abstract: A method of controlling algae in a municipal water plant including the step of adding an algicide-flocculant solution including 25-50 wt % acidic flocculent, 0-10 wt % polymer flocculant aid, an algicide consisting essentially of copper having a concentration of 0.025-1.275 wt % in the form of a water soluble copper salt, balance water. The algicide-flocculant solution may be added to the water via a clarifier of the water plant, a basin of the water plant, or a mixing chamber. The mixing chamber may be located within the clarifier, adjacent to the basin, or upstream of the clarifier and/or the basin.Type: GrantFiled: June 18, 2001Date of Patent: June 10, 2003Assignee: Bay Chemical and Supply CompanyInventors: Thomas J. Nier, Tosby L. Linn
-
Patent number: 6541038Abstract: A method for treating wood, characterized by impregnating wood with a metal-containing treating agent containing lignin and/or lignin derivatives and a metal, a metal compound, and/or a metal ion and oxidizing and/or macromolecularizing of the lignin and/or lignin derivatives in the wood to fix the metal component in the wood, and wood and woody materials obtained by the treating method. According to the method of the present invention, while effectively utilizing lignins, lignosulfonic acids, or lignosulfonic acid salts, leaching of the metal component can be suppressed to a low level to thereby retain the effects due to the incorporation of the metal components for a prolonged period.Type: GrantFiled: May 25, 2000Date of Patent: April 1, 2003Assignee: SDS Biotech K.K.Inventors: Keijitsu Tanaka, Hirobumi Aoki, Takashi Echigo
-
Patent number: 6468518Abstract: Animal enclosures such as poultry houses generate high amounts of ammonia that adversely affect weight gain and mortality or the animals, particularly among young chicks. The addition of a deliquescent salt, such as calcium chloride, to alum to treat animal waste products rapidly activates the alum to remove ammonia from the atmosphere. The ammonia sulfate by-product is useful as a nitrogen fertilizer.Type: GrantFiled: February 8, 2001Date of Patent: October 22, 2002Assignee: General Chemical CorporationInventors: Christopher Bruce Lind, Joseph Lewis Hurd, Russell Hayden Barnes
-
Patent number: 6420312Abstract: An algicide-flocculant solution for use in treating raw water in a municipal water plant to control algae, the algicide-flocculant solution including 25-50 wt % of an acidic flocculant, 0-10 wt % of a polymer flocculant aid, an algicide of essentially copper having a concentration of 0.025-1.25 wt % in the form of a water soluble capper salt, and balance water. Uniform mixing of the flocculant into the raw water simultaneously uniformly mixes the algicide of the algicide-flocculant solution into the raw water. The acidic flocculant is preferably aluminium sulfate, iron sulfate, iron chloride or mixtures thereof. The water soluble copper salt is preferably copper sulfate, copper chloride, copper nitrate, copper acetate or mixtures thereof. Moreover, the flocculant aid is a high molecular weight quaternary amine such as diallyldimethylammonium chloride.Type: GrantFiled: June 11, 2001Date of Patent: July 16, 2002Assignee: Bay Chemical and Supply CompanyInventors: Thomas J. Nier, Tosby L. Linn
-
Patent number: 6416790Abstract: The concentrate is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a specific conductance of less than 0.10 microhmo to about 1.2 to 3 parts by volume of Willard Water as prepared in accordance with U.S. Pat. No. 3,893,943. The liquid concentrate is applied directly to a skin surface area having a burn or other dermal lesion to protect the area from bacterial contamination.Type: GrantFiled: March 13, 2000Date of Patent: July 9, 2002Assignee: Aqua Med, Inc.Inventor: John D. Young
-
Patent number: 6350474Abstract: The invention deals with phosphate water solution with cold solidification capacity. Phosphate composition containing iron oxide solution in acid, water, advantages from the following properties; it contains orthophosphorus acid and in addition metal powder. Phosphate composition is ecologically pure product, non toxic, non cancerogenic, non-allergic. It has antimicrobial, antivirus and fungicidal properties. Phosphate composition can be applied within medicine: surgery, dermatology, dentistry, oncology, pharmacology and other branches. In agriculture use: as a means of curing plant diseases, within veterinary—as a means for preventive maintenance and curing of animal diseases, within construction—as an anticorrosive, fire-resistant, hydro-electric isolating covers, ceramic tiles, concretes, which protect against radiation, as well as for producing other composite materials.Type: GrantFiled: June 7, 1999Date of Patent: February 26, 2002Inventors: David Dzneladze, Andro Dzneladze, Nargisa Jabishvili
-
Patent number: 6346240Abstract: A method of treating liquid animal manure comprising contacting a manure slurry with a treatment composition comprising a treatment effective amount of AlCl3.nH2O or Al(NO3)3.mH2O, or the residue of AlCl3.nH2O or Al(NO3)3.mH2O, to form a resulting slurry, wherein n is from 0 to 10, and m is from 0 to 12. The treatment effective amount is effective to reduce phosphorus solubility in the manure; reduce phosphorus runoff and/or phosphorus leaching from fields fertilized with manure; inhibit ammonia volatilization from the manure; flocculate solids in the manure; reduce pathogens in the manure; increase the nitrogen content in the manure; and/or reduce acid rain and PM-10s associated with the manure.Type: GrantFiled: October 22, 1998Date of Patent: February 12, 2002Assignees: The United States of America as represented by the Secretary of Agriculture, The Board of Trustees of the University of ArkansasInventor: Philip A. Moore, Jr.
-
Publication number: 20010009682Abstract: This invention relates to disinfectant concentrates having improved biocidal activity containing an aldehyde, such as glutaraldehyde, a glycol and a lithium based buffer.Type: ApplicationFiled: August 13, 1999Publication date: July 26, 2001Applicant: L'OREALInventor: REGINALD KEITH WHITELEY
-
Patent number: 6248369Abstract: A water soluble copper salt, preferably cupric sulfate pentahydrate, is mixed with water. A small quantity of an acidic flocculant is added to the copper sulfate solution to acidify the water and promote dissolving of the copper sulfate in the water. A 25-50% water solution of an acidic flocculant, with or without a cationic polymeric flocculant aid, is prepared and pumped into a processing vessel or tank. The acidified copper sulfate solution is added to the tank and mixed with the acidic flocculant. The algicide-flocculant solution is transported to a municipal water plant and added to raw water in the clarifier to drop out particulates in the incoming water and control algae in the clarifier.Type: GrantFiled: April 6, 1998Date of Patent: June 19, 2001Assignee: Bay Chemical and Supply CompanyInventors: Thomas J. Nier, Tosby L. Linn
-
Patent number: 6027730Abstract: Novel herpes simplex (HSV) vaccine formulations are provided. These comprise HSV glycoprotein gD or immunological fragments in conjunction with 3 Deacylated monophosphoryl lipid A.Type: GrantFiled: September 9, 1994Date of Patent: February 22, 2000Assignee: Smithkline Beecham BiologicalsInventors: Myriam Francotte, Jean-Paul Prieels, Moncef Slaoui, Nathalie Marie-Josephe Claude Garcon-Johnson
-
Patent number: 6020005Abstract: A genital wart treatment for treating and removing genital warts. The genital wart treatment includes the acts of dissolving a volume of particulate potassium permanganate in a volume of water to form a treatment solution, and repeatedly performing over a duration of time a treatment application comprising the acts of applying the treatment solution on to genital warts and surrounding skin of a subject to wet the genital warts and surrounding skin with the treatment solution, applying a styptic to the wet genital warts and surrounding skin, and then removing an outermost layer of skin on the genital warts.Type: GrantFiled: April 8, 1999Date of Patent: February 1, 2000Inventor: Ervin G. Weathers
-
Patent number: 6001348Abstract: The present invention provides NAD-independent Mycoplasma synoviae of strain MS1. The invention also refers to microbiological cultures comprising Mycoplasma synoviae of this strain. Next to this, the invention refers to live vaccines derived from these strains, for the protection of poultry against Mycoplasma synoviae infection. Furthermore, the invention provides methods for the preparation of such vaccines. Also, the use of NAD-independent Mycoplasma synoviae strains for the preparation of live vaccines for the protection of poultry against Mycoplasma synoviae infection is disclosed.Type: GrantFiled: December 5, 1997Date of Patent: December 14, 1999Assignee: Akzo Nobel N.V.Inventor: Maarten Hendrik Witvliet
-
Patent number: 5961968Abstract: A method for treating poultry litter which inhibits ammonia volatilization and reduces soluble phophorus levels in the litter. The method comprises the addition of alum to litter in an amount sufficient to maintain the litter pH at values low enough to inhibit ammonia volatilization. The addition of alum, iron or calcium compounds to litter also effectively precipitates soluble phosphorus in litter, thereby reducing the amount of soluble phosphorus runoff from fields receiving litter.Type: GrantFiled: May 1, 1996Date of Patent: October 5, 1999Assignees: Trustees of University of Arkansas, The United States of America as represented by the Secretary of AgricultureInventor: Philip A. Moore, Jr.
-
Patent number: 5955112Abstract: A non-stinging styptic composition in the form of a water soluble resin coated cast pencil, for stopping bleeding from cuts and nicks received during shaving. The composition comprises aluminum sulfate, aloe, glycerine, lidocaine and polyethylene glycol 400.Type: GrantFiled: February 11, 1998Date of Patent: September 21, 1999Inventor: Jeffrey Kaplan